Table 3.
PCH analysis of SMALP encapsulated ABCG2, and monomeric (CD86) and dimeric (CD28) controls.
| Protein | Component 1 |
Component 2 |
||
|---|---|---|---|---|
| Fraction (%) | ε (cpm.s−1) | Fraction (%) | ε (cpm.s−1) | |
| ABCG2 | 94.6 ± 1.6 | 51,999 ± 2135 | 5.4 ± 1.6 | 408,163 ± 12,498 |
| CD28 | 93.8 ± 1.3 | 60,030 ± 7406 | 6.2 ± 1.3 | 465,789 ± 71,770 |
| CD86 | 93.0 ± 1.5 | 27,074 ± 6975 | 7.0 ± 1.5 | 271,957 ± 47,354 |
Fluorescence fluctuations were analysed by PCH analysis using a 2-component model as described in the text. Values given represent the mean ± SD for three independent experiments.